Petrocca F - Search Results

1

miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes.

Perdigão-Henriques R, Petrocca F, Altschuler G, Thomas MP, Le MT, Tan SM, Hide W, Lieberman J. Perdigão-Henriques R, et al. Among authors: petrocca f. Oncogene. 2016 Jan 14;35(2):158-72. doi: 10.1038/onc.2015.69. Epub 2015 Mar 23. Oncogene. 2016. PMID: 25798844 Free article.

2

Micromanipulating cancer: microRNA-based therapeutics?

Petrocca F, Lieberman J. Petrocca F, et al. RNA Biol. 2009 Jul-Aug;6(3):335-40. doi: 10.4161/rna.6.3.9013. Epub 2009 Jul 14. RNA Biol. 2009. PMID: 19535911 Review.

3

A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cells.

Petrocca F, Altschuler G, Tan SM, Mendillo ML, Yan H, Jerry DJ, Kung AL, Hide W, Ince TA, Lieberman J. Petrocca F, et al. Cancer Cell. 2013 Aug 12;24(2):182-96. doi: 10.1016/j.ccr.2013.07.008. Cancer Cell. 2013. PMID: 23948298 Free PMC article.

4

Gene Knockdown by EpCAM Aptamer-siRNA Chimeras Suppresses Epithelial Breast Cancers and Their Tumor-Initiating Cells.

Gilboa-Geffen A, Hamar P, Le MT, Wheeler LA, Trifonova R, Petrocca F, Wittrup A, Lieberman J. Gilboa-Geffen A, et al. Among authors: petrocca f. Mol Cancer Ther. 2015 Oct;14(10):2279-91. doi: 10.1158/1535-7163.MCT-15-0201-T. Epub 2015 Aug 11. Mol Cancer Ther. 2015. PMID: 26264278

5

Micromanagers of immune cell fate and function.

Petrocca F, Lieberman J. Petrocca F, et al. Adv Immunol. 2009;102:227-44. doi: 10.1016/S0065-2776(09)01204-8. Adv Immunol. 2009. PMID: 19477322 Review.

6

miR-200 enhances mouse breast cancer cell colonization to form distant metastases.

Dykxhoorn DM, Wu Y, Xie H, Yu F, Lal A, Petrocca F, Martinvalet D, Song E, Lim B, Lieberman J. Dykxhoorn DM, et al. Among authors: petrocca f. PLoS One. 2009 Sep 29;4(9):e7181. doi: 10.1371/journal.pone.0007181. PLoS One. 2009. PMID: 19787069 Free PMC article.

7

Promise and challenge of RNA interference-based therapy for cancer.

Petrocca F, Lieberman J. Petrocca F, et al. J Clin Oncol. 2011 Feb 20;29(6):747-54. doi: 10.1200/JCO.2009.27.6287. Epub 2010 Nov 15. J Clin Oncol. 2011. PMID: 21079135 Review.

8

RIG-ing an antitumor response.

Petrocca F, Lieberman J. Petrocca F, et al. Nat Med. 2008 Nov;14(11):1152-3. doi: 10.1038/nm1108-1152. Nat Med. 2008. PMID: 18989278 No abstract available.

9

Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival.

Chan S, Sridhar P, Kirchner R, Lock YJ, Herbert Z, Buonamici S, Smith P, Lieberman J, Petrocca F. Chan S, et al. Among authors: petrocca f. Mol Cancer Ther. 2017 Dec;16(12):2849-2861. doi: 10.1158/1535-7163.MCT-17-0461. Epub 2017 Sep 6. Mol Cancer Ther. 2017. PMID: 28878028 Free PMC article.

10

Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer.

Witt AE, Lee CW, Lee TI, Azzam DJ, Wang B, Caslini C, Petrocca F, Grosso J, Jones M, Cohick EB, Gropper AB, Wahlestedt C, Richardson AL, Shiekhattar R, Young RA, Ince TA. Witt AE, et al. Among authors: petrocca f. Oncogene. 2017 Mar 23;36(12):1707-1720. doi: 10.1038/onc.2016.337. Epub 2016 Oct 3. Oncogene. 2017. PMID: 27694895 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page